Analysis:

**(a) Source Analysis**

1. **Programmatic Historical Distribution (DD price data, N=2,506 windows)** – Highest quality. Directly computed from DD's actual price history. Unconditional P(up over 9 trading days) = 55.3%. Conditional filters applied. This is the primary anchor.

2. **MarketBeat analyst summary (Feb 11, 2026)** – Good quality financial aggregator. Factual: Wells Fargo raised PT to $55 (overweight), KeyCorp to $57, UBS to $56, Mizuho to $52. Consensus "Moderate Buy," average PT ~$49.46 (slightly below current price of ~$50). Q4 EPS beat ($0.46 vs $0.43 estimate). FY2026 guidance $2.25-$2.30 EPS. $2B buyback authorized. Insider selling noted (CEO, SVP at ~$39-40/share in November). Short interest rose ~23.6%.

3. **MarketBeat institutional filing summary (Feb 27, 2026)** – Good quality. Factual: Primecap reduced stake 8%. Dividend: $0.20/share quarterly, **ex-dividend date March 2, 2026**, payment March 16. Average analyst PT $51.86. Stock opened at $50.32. 52-week high $52.66.

4. **MarketBeat Mondrian Investment Partners filing (Feb 17, 2026)** – Good quality. Factual: Mondrian acquired 1.78M shares (~$138.5M). Multiple analyst upgrades post-earnings. Consensus PT $50.46.

5. **GuruFocus articles (March 1, 2026)** – Moderate quality. Factual: Morgan Stanley Pathway ETF bought 1,392 DD shares. Guggenheim increased stake 751%. Dividend record date March 2, payment March 16. Stock opened at $49.86. 52-week high $52.66.

6. **Defense World/Allianz SE article (March 1, 2026)** – Moderate quality. Factual: Allianz reduced DD stake 32.9%. Stock opened at $50.05. Analyst PTs range $52-$59. Average PT $51.86.

7. **Stockpulse daily trading summaries (Feb 12 – Feb 27, 2026)** – Moderate quality, automated reports. Factual price data: DD traded around $49.70-$51.53 range in late February. 52-week high $52.66 on Feb 12. Stock has risen ~15.54% since end of January.

8. **Seeking Alpha Q4 2025 Earnings Call (Feb 10, 2026)** – High quality. Factual: CEO Lori Koch guided 3% organic sales growth, EPS $2.25-$2.30 for 2026. 60-80 bps margin expansion expected.

9. **Nasdaq DD March 2026 Options article** – Moderate quality, but appears to reference DD at ~$76.54 which is inconsistent with current price (~$50). Likely outdated or erroneous data. **Discounted heavily.**

10. **Barchart SONIA futures articles** – Irrelevant to DD. No weight.

11. **AskNews deep research summary** – Moderate quality synthesis. No specific litigation or major contract news for DD in Feb-March 2026. Confirms earnings guidance and restructuring context (abandoned water business spin-off in Jan 2025, completed electronics separation).

**(b) Evidence Analysis**

**Strong evidence:**
- **Historical base rate (55.3% P(up) over 9 trading days)**: The most reliable anchor. N=2,506 windows, directly applicable.
- **Ex-dividend date is March 2, 2026**: The reference close price on March 2 will be the ex-dividend price (already reduced by ~$0.20). This means the March 13 close only needs to exceed the ex-dividend price, not the cum-dividend price. This mechanically provides a slight tailwind (~+2 pp) since the bar to clear is lower than it would otherwise be.

**Moderate evidence:**
- **Multiple analyst upgrades post-Q4 earnings**: Citigroup ($59), Deutsche Bank ($58), KeyCorp ($57), Jefferies ($59), Wells Fargo ($55), UBS ($56), Mizuho ($52) – all above current price of ~$50. Average PT ~$51.86. This represents a consensus view of ~4% upside from current levels, which is directionally positive but modest for a 9-day window. Moderate positive signal.
- **$2B share buyback program**: Authorized Nov 6, representing 12.2% of shares. Active buyback provides price support. Moderate positive.
- **Strong recent momentum**: +15.54% since end of January, +29.69% over 3 months (94th percentile historically). Conditional P(up) when 3-month return >20% = 58.5% (+3.2 pp). Moderate positive.
- **Price near 52-week high ($52.66 on Feb 12)**: Current price ~$50 is near the top of the 52-week range. Conditional P(up) when price in top decile = 50.1% (-5.2 pp). Moderate negative.

**Weak evidence:**
- **Insider selling (CEO, SVP at ~$39-40 in November)**: Occurred at much lower prices, so less informative about current valuation views. Weak negative.
- **Short interest rose 23.6% in January to ~9.24M shares (~2.2% of float)**: Modest short interest, not extreme. Weak negative.
- **Allianz reduced stake 32.9%**: One institutional seller among many buyers. Weak negative.
- **No major catalysts in the 9-day window**: No earnings, no major M&A news. Neutral/weak.
- **Macro uncertainty**: General market volatility (tariffs, CPI release around March 10-12). Weak negative.

**(c) Timeframe Analysis**

The prediction window is **9 NYSE trading days** (March 2 to March 13, 2026). This is a very short horizon.

- **If halved (~4-5 days)**: The base rate would be closer to 50-52% (less time for mean-reversion or momentum to play out, more noise). The ex-dividend effect would be slightly more concentrated.
- **If doubled (~18 days)**: The base rate would approach ~57-58% (more time for positive drift and analyst PT convergence). The buyback support would have more time to work.

The current 9-day window is short enough that random walk dominates. The CPI release (likely around March 10-12) adds macro uncertainty but is not specifically negative for DD.

**(d) Justification**

Starting from the outside view of **55.3%**:

1. **Ex-dividend adjustment (+2 pp)**: The March 2 close will be ex-dividend (record date March 2, ex-date March 2). The reference price is already the ex-dividend price, so the bar to clear is lower by ~$0.20. Historically, dividend stocks tend to partially recover the ex-dividend drop within 2 weeks. This adds approximately +2 pp.

2. **Analyst consensus above current price (+1 pp)**: Average PT of $51.86 vs. current ~$50 represents ~4% upside. Multiple credible analysts (Citigroup, Deutsche Bank, KeyCorp, Jefferies) have PTs of $57-$59. This creates a modest directional pull. However, analyst PTs are not reliable short-term predictors, so I apply only +1 pp.

3. **Price near 52-week high (-2 pp)**: Being in the top decile of the 52-week range historically reduces P(up) by 5.2 pp. However, this is partly offset by the strong momentum factor (+3.2 pp for 3-month return >20%). Net effect: approximately -2 pp.

4. **Elevated volatility (+1 pp)**: 30-day realized vol of 34.9% (annualized) is above median, historically associated with P(up) = 57.2% (+1.9 pp). I apply +1 pp.

5. **No major catalysts in window (-1 pp)**: Without a clear positive catalyst, the stock may drift or consolidate after its strong recent run. The macro environment (tariff uncertainty, CPI) adds modest downside risk. -1 pp.

Net adjustments: +2 +1 -2 +1 -1 = +1 pp

**Inside view estimate: 55.3% + 1% ≈ 56%**

This aligns with the outside view of 56%, confirming the adjustments are modest and the base rate is the dominant factor.

---

**Probability Calibration**

The base rate is 55.3%. My adjustments are small and partially offsetting. The ex-dividend effect is the clearest directional signal (+2 pp), but it's partially already in the historical base rate (which includes many ex-dividend periods). The analyst consensus is positive but not predictive on a 9-day horizon. The near-52-week-high effect is a modest headwind. 

I settle on **56%** as my inside view prediction.

---

**Checklist:**

1. **Paraphrase**: Will DD's closing price on March 13, 2026 be higher than its closing price on March 2, 2026? (9 trading days)

2. **Outside view base rate**: 55.3% (historical 9-day positive return rate for DD, N=2,506). Final prediction of 56% is rooted in this base rate with small adjustments.

3. **Consistency check**: "56 out of 100 times, DD closes higher on March 13 than March 2." This makes sense given the slight positive drift in equity markets and the specific factors identified.

4. **Most significant evidence**:
   - Historical base rate: 55.3% P(up) over 9 trading days (strong, directly applicable)
   - Ex-dividend date March 2 lowers the reference bar by ~$0.20 (moderate positive)
   - Price near 52-week high historically reduces P(up) by ~5 pp (moderate negative)
   - Strong 3-month momentum (>20%) historically adds ~3 pp (moderate positive)
   - Multiple analyst PTs above current price (~$51.86 avg) (moderate positive)

5. **Blind spot**: A broad market selloff driven by tariff escalation or CPI surprise in the March 10-12 window could push DD down 5-8% given its elevated beta (1.10) and recent run-up. This scenario could reduce probability to ~45%.

6. **Status quo**: DD has been trading in a $49-52 range for several weeks. The status quo of sideways trading would result in roughly 50/50 odds. My 56% reflects a slight positive tilt from the base rate.

Probability: 56%